Semmelweis University

At Semmelweis University, a major share of clinical research focuses on digestive system diseases, especially Crohn’s disease and ulcerative colitis. These studies are largely designed to test new therapies and better understand how to achieve and maintain disease control in people living with chronic intestinal inflammation.

• Research on Crohn’s disease and ulcerative colitis is prominent across adult and pediatric populations.
• Trials also explore related conditions such as short bowel syndrome and Clostridioides difficile infection.
• Several studies aim to improve remission rates, symptom control, and long-term treatment effectiveness.

The site’s activity in this field reflects a strong interest in advancing both new treatment options and ongoing care strategies for chronic gastrointestinal disease.

Clinical trials at this site also cover a broad range of cardiovascular diseases and nutritional and metabolic diseases, including heart failure, coronary artery disease, stroke, hypertension, and obesity. The research often seeks to evaluate treatment effectiveness, reduce risk of future events, and improve long-term outcomes in high-risk patients.

• Studies address heart failure, myocardial infarction, and atrial fibrillation.
• Metabolic research includes hyperlipidemia, hypercholesterolemia, and type 2 diabetes.
• Some trials focus on preventing complications such as recurrent stroke or worsening cardiac function.

This cardiovascular portfolio highlights a strong emphasis on prevention, risk reduction, and improving care for chronic heart and metabolic conditions.

The research landscape includes extensive work in neoplasms, with studies in lung cancer, breast cancer, prostate cancer, colorectal cancer, and multiple blood cancers such as leukemia, lymphoma, and multiple myeloma. These trials are primarily aimed at testing new cancer therapies and improving disease control in both solid and blood-related tumors.

• Common areas include non-small cell lung cancer, small cell lung cancer, and metastatic solid tumors.
• Blood cancer studies cover acute myeloid leukemia, diffuse large B-cell lymphoma, and myelofibrosis.
• Some projects focus on improving survival, slowing progression, or supporting treatment after standard care.

Semmelweis University appears to be an active site for oncology research spanning both common cancers and more specialized rare malignancies.

Another important area of research involves eye diseases, especially diabetic macular edema, age-related macular degeneration, diabetic retinopathy, and other retinal conditions. These trials generally aim to improve vision-related outcomes, compare treatment effectiveness, and assess longer-term eye health.

• Studies include wet age-related macular degeneration and geographic atrophy.
• Research also addresses macular edema linked to retinal vein occlusion and diabetes.
• The goal is often to preserve vision and evaluate whether new approaches can offer better disease control.

This field shows a clear focus on helping patients with chronic retinal disease maintain sight and daily function.

Clinical trials in nervous system diseases and psychiatry and psychology cover conditions such as epilepsy, migraine, multiple sclerosis, Alzheimer’s disease, schizophrenia, and major depressive disorder. The purpose of this research is often to improve symptom relief, support long-term management, and evaluate new treatment options for complex neurological and psychiatric illnesses.

• Epilepsy studies include focal seizures and generalized seizures.
• Other work examines migraine prevention, multiple sclerosis, and cognitive decline.
• Psychiatric trials explore treatment options for depression and schizophrenia.

The breadth of this research shows a strong commitment to disorders that affect thinking, movement, mood, and quality of life.

The Gyermekgyogyaszati Klinika supports a wide range of pediatric and specialty studies involving congenital diseases, immune system diseases, musculoskeletal disorders, and rare inherited conditions. Many trials are designed to test new therapies in children, improve safety and tolerability, or refine treatment approaches for uncommon but serious illnesses.

• Research includes biliary atresia, spinal muscular atrophy, and juvenile idiopathic arthritis.
• Immune-focused studies address myasthenia gravis, immune thrombocytopenia, and systemic lupus erythematosus.
• Additional work covers rare genetic and developmental disorders in younger patients.

This pediatric portfolio reflects a broad effort to bring innovative care to children with complex, chronic, and often rare diseases.

Trials at Semmelweis University also extend into respiratory tract diseases, kidney disease, and bacterial infections. These studies are generally focused on improving treatment effectiveness, preventing complications, and supporting patients with severe or long-lasting illness.

• Respiratory research includes asthma, COPD, bronchiectasis, and pulmonary fibrosis.
• Renal studies address chronic kidney disease, IgA nephropathy, and transplant-related issues.
• Infectious disease work includes sepsis, pneumonia, and serious gram-negative infections.

These programs show a practical focus on conditions that can lead to hospitalization, long-term disability, or major complications if not managed effectively.